In conclusion, MEAO efficiently attenuated ER stress and prevented the development of hepatic steatosis through inhibition of the expression of hepatic lipogenic genes and of VLDLR, and enhancement of ApoB secretion. The gene discussed is VLDLR; the disease is fatty liver disease.